Objective: to assess the potential of antenatal surveillance data on HIV prevalence in young women as an indicator of trends in HIV incidence.
Introduction
Reliable data on HIV incidence are essential for monitoring the spread of HIV and for assessment of the impact of sexual health interventions. Unfortunately, HIV incidence data are difficult and costly to collect and therefore limited to localized cohort studies. At the national and subnational levels HIV prevalence data will continue to be the main source for monitoring the epidemic and assessment of the impact of interventions to reduce HIV transmission. Several methods have been used to estimate HIV incidence from prevalence data from a single survey or from multiple survey rounds by making assumptions about constant incidence rates, steady state conditions, and mortality rates among diseased subjects [1] [2] [3] [4] .
Prevalence data may be collected in population-based surveys or from sentinel or target populations. Women attending antenatal clinics are the predominant source of HIV prevalence data in most countries with generalized epidemics, especially in sub-Saharan Africa. Many countries have data on trends in HIV prevalence among antenatal women [5] . The extent to which HIV trends among antenatal women reflect trends in the general population depends on the severity of a number of biases. If antenatal attendance is high, as in most countries of subSaharan Africa, women attending antenatal clinics are likely to be typical of all pregnant women. However, the representativeness of pregnant women for the general female population of reproductive ages has been challenged -partly because of lower fertility in HIV infected women and partly because of selection for sexual activity [6] . Comparison of HIV prevalence between antenatal clinic and population-based samples in six African studies showed that antenatal women have lower HIV prevalence than the general female population in all age groups except the youngest (under 20 years).
HIV incidence and prevalence trends among young women are of particular relevance for monitoring of the AIDS epidemic. First, the dynamics of the HIV epidemic in young women have a very large influence on the overall course of the epidemic, because young women are a high proportion of the total population. Second, in several populations, incidence rates among young women are among the highest observed [7, 8] . Third, young women may be more likely than older women to respond to interventions with changes in behaviour. For example, declines in HIV prevalence among young antenatal women in Uganda have been attributed to behavioural change and possibly to interventions [9, 10] . Finally, effects of HIV-associated reduction in fertility or increases in mortality are likely to be less pronounced among recently infected young women. By focusing on younger individuals fewer assumptions have to be made in order to estimate incidence from prevalence and hence the incidence estimates may be more robust [11] .
For these reasons, HIV prevalence among 15-24-year-old women attending antenatal clinics has been selected as one of the key indicators for monitoring HIV prevention programmes [12, 13] . Some authors have even suggested that sentinel surveillance should focus on narrower age groups of young women, such as 15-19 years [10] or 18-21 years [14] . This paper investigates whether and how data on HIV prevalence among young women from antenatal clinics could be used to estimate trends in HIV prevalence and incidence in the general female population. In particular, the advantages and limitations of age-based measures (15-19 and 15-24 years) are assessed. Biases may occur related to age reporting, sexual behaviour, contraceptive use, and fertility. Parity-specific HIV prevalence avoids some of the reporting biases associated with age and is discussed as an additional method to age-based prevalence measurement in antenatal clinic settings. Models are used to assess the robustness of the different measures, both in rapidly evolving epidemics and in steady-state conditions. In both sets of studies there is a strong linear relationship between HIV prevalence at 15-24 and prevalence in the reproductive ages as a whole (15-49 years in most studies), as shown in Figure  1 (a). Regression lines indicate that correlation is stronger in antenatal studies than in population based studies (r2 = .96 and .88 respectively), and that the relationship is closer to simple proportionality in antenatal studies (regression intercepts = 0.0 and 1.1 percentage points respectively). This may be due to transient incompatibility of experience in younger and older women in the cross-sectional measures: prevalence levels at ages 15-24 reflect only recent incidence rates, prevalence in the age range 15-49 is the result of exposure to historical and recent incidence. The population based data in Figure 1 are derived from communities with a mixture of old and new, rapidly growing and almost stable epidemics, so differences between age group experience will be quite variable. By contrast, antenatal data generally represent prevalence due to recent infections, since at longer durations of infection women become less fertile and thus less likely to present at antenatal clinics [15] .
HIV prevalence by age
Figure 1(b) shows that prevalence measures in the 15-19 age group are not as strongly correlated to all age prevalence measures (r2 = .86 and .75 in antenatal and population based studies respectively) than the corresponding relationships in the 15-24 age group illustrated in Figure  1 (a); also the relationships are not as close to simple proportionality, with larger regression intercepts (2.0 and 3.4 respectively).
The last panel of Table 1 shows incidence data from the few available longitudinal community based studies, classified by age as in the first two panels. It is clear that incidence at 15-24 is appreciably higher than in the population as a whole, but the relationship to all age incidence is reasonably proportionate, with a correlation coefficient close to one (r2 = .94) and a small regression intercept (0.3). This relationship is stronger than the corresponding relationship in the 15-19 age group (r2 = .88, intercept 0.7). Direct comparisons between prevalence and incidence measures for the same population would tell us much about the predictive power of prevalence data from young women as a measure of incidence, but published data do not allow this -in particular, it is only for Blantyre in Malawi that we have both antenatal clinic prevalence measures as well as data on incidence.
More than half of all women in the childbearing ages are in the age group 15-24 (table 1) ; the median proportion is 57% (range 28-67%) in the 17 antenatal care studies and 53% (range 41-66%) in the 10 population-based surveys. There is however considerable variation in the proportion of women 15-19 relative to 20-24. At the low end, only 22% of antenatal women 15-24 in Rwanda were aged under 20 years. At the high end, more than half of antenatal women 15-24 were under 20 years in Fort Portal, Uganda. Differences in age at first pregnancy are likely to be important determinants of this proportion. As HIV prevalence increases rapidly in the early phase of sexual activity, fluctuations in the age composition within the age groups 15-19 or 15-24 will affect the overall prevalence estimate: the younger the sample, the lower the prevalence in the age group, but virtually no studies provide data by single years of age.
HIV prevalence estimates by single-year age group, however, do not appear a feasible option. The prohibitive costs of the large samples needed to obtain sufficient numbers by single years of age make it necessary to work with larger age groups. Hitherto, most HIV sentinel surveillance clinics aimed to have samples of about 300-500 women in all age groups in a calendar year. To monitor trends in HIV prevalence an adequate number of women need to be included, as fairly large numbers of women are required to detect significant changes. For example, slightly over 1,000 women are required to be 80% confident of being able to detect a decrease from 10% to 7% at the 95% level of significance (not taking into account a design effect). For the prevention indicator (HIV prevalence among 15-24-year-olds) WHO recommended a sample size of 3,000 women in the age group 15-24 years to monitor HIV trends [12] .
Age misstatement is common in countries where the respondents do not know their exact birth date. The effects of age misstatement are more serious if smaller age groups are used. Heaping on 20 years of age can be considerable and could have an effect on prevalence monitoring, especially if 15-19 and 20-24 age groups are separated. Also young pregnant women may report an older age at the antenatal clinic, especially if there is popular concern about early pregnancies, e.g. due to reproductive health interventions aimed at reducing adolescent pregnancy. This bias may be more serious for premarital pregnancies.
Another issue is the choice of a lower cut-off point for the age range. Most antenatal care clinics and population-based surveys report data from age 15 onwards. In some countries HIV prevalence data are reported separately for girls under 15 who attend antenatal clinics. In 1977 in South Africa, HIV prevalence was 9.5% among 42 pregnant girls under 15, however they constituted only 0.7% of all antenatal women under 25 [16] . In Malawi in 1977, no pregnant girl under 15 was HIV positive and girls under 15 accounted for 0.5% of all antenatal women under 25 years [17] . Population-based studies that have included girls under 15 years have generally found HIV prevalence rates of less than 1 percent (e.g. in Rakai, Uganda [18] , and in Addis Ababa, Ethiopia, [11] , with the exception of Rwanda in 1997, where a prevalence of 4.0% was reported in the 12-14 age group [19] . Inclusion of 12-and 14-year-olds would have a major depressing influence on prevalence in the age group described as "under 20 years", as most of them are negative (in fact, most are not yet sexually active) and because younger girls are more numerous than older ones. Therefore, exclusion of women under 15 in monitoring HIV prevalence is justified for most populations.
HIV prevalence by parity
Most antenatal clinics routinely collect data on the rank order of the pregnancy and often such data are also reported in HIV sentinel surveillance, but rarely analyzed. Pregnancies can be ranked by a woman's parity (number of previous live births) or gravidity (number of previous pregnancies), so that it should be possible to obtain HIV prevalence categorized by parity or gravidity. In Malawi in 1997, women at their first and second pregnancy represented 50.7% of the total sample and HIV prevalence among these women was 20.6%, compared to 20.4% among women aged 15-24 [17] . HIV prevalence peaked at the second pregnancy. Table 2 shows that this is typical for most settings where such data have been analyzed. Figure 1 indicates that the proportionate relationship between prevalence in all pregnant women and women experiencing their first or second pregnancy is somewhat weaker than the corresponding relationship for the age based measure, due to the relatively wide scatter of points in populations with low HIV prevalence.
Ideally, a pregnancy history should include previous abortions, stillbirths and live births. Often, however, abortions are underreported and since many women tend to make their visit to antenatal clinics late in pregnancy (usually in the second trimester) pregnancies that lead to abortion are completely missed. In non-contracepting populations, the birth order or parity of a young pregnant woman would tend to be a more precise measure of her sexual exposure than her age, especially if there is wide variation in the age at first sex, or if initial sexual contacts are sporadic and infrequent. As a measure of length of exposure to unprotected sex, gravidity would be even more precise, as this accounts for the number of abortions as well. But in view of the reporting problems inherent in classifying women by gravidity, data classified by parity would be more robust.
Population-based sero-surveys may also classify women by parity, although the figures are not strictly comparable to the antenatal clinic data since antenatal women are closer to progressing to the next parity (they are pregnant) than women in a community survey (the proportion of women pregnant at the time of the survey is usually small). Also, the population-based data will include women who will never progress to the next parity, either because of secondary sterility or due to their partnership circumstances -these women are completely missed in antenatal HIV surveillance. Table 1 also shows incidence data from the few available longitudinal community based studies, classified by the same age intervals as used for prevalence in the first two panels. These data are also plotted in Figure 1 . Although only five data points are available, they do suggest a simple proportionate relationship between incidence at 15-24 and incidence in females of reproductive age. It is clear that incidence at 15-24 is appreciably higher than in the population as a whole.
Modelling time trends in incidence and prevalence
A simple projection model has been constructed to study the expected relationship between prevalence and incidence measures in young women when incidence changes over time. This model predicts prevalence in all women 15-24, as well as in pregnant women, and allows us to look at the effects of classifying pregnant women either by age or by parity. The equations formally defining the model are given in appendix A, and a brief, non-technical explanation of its main features follows.
The simulated population represents females aged 10 to 29 followed for 25 years from the baseline calendar year, distinguishing single year age groups and time periods. The population is assumed to arise from birth cohorts growing at 2% per year, and adult mortality from non-HIV causes is assumed to be 0.5% p.a. at all ages -under these initial conditions, one five year age group is about 13% larger than the next one. At the baseline the prevalence of HIV is assumed to be zero, but non-zero incidence among the sexually active is allowed to start within the first projection year. HIV incidence among the sexually active is assumed to be independent of age, but is allowed to vary by calendar year. Incidence is measured as an annual risk for those currently HIV negative, prevalence is a cross sectional measure with HIV positive and negative in the denominator.
The cumulated risk function describing the start of sexual activity by virgins in a given calendar year is assumed to have the form of a logistic curve, whose location and slope can be varied. The default pattern, which is assumed to have been operating up to and including year zero in the simulations shown below, stipulates that 1% of women have become sexually active by age 12, and 99% have become sexually active by age 17. The cohort pattern of sexual debut is allowed to change over time, but once a woman has become sexually active she remains so until we lose sight of her when she reaches the age of 30.
The sexually active are assumed to have a fixed annual risk of giving birth which is independent of age -in the simulations below the annual risk is 30%. This means that the parity distribution of a cohort is determined only by the distribution of the women by time since sexual debut. The simulations below do not assume any differences in risk of giving birth between the HIV negative and the HIV positive.
The main input assumption driving the model is the annual rate of HIV incidence among the sexually active, but the pattern of sexual debut, which determines the proportion sexually active by age is also an important determinant of overall incidence and prevalence. If sexual debut is early, incidence among women aged 15-24 is virtually the same as incidence among the sexually active; if it is late, incidence in the population aged 15-24 is lower than in the sexually active as there are significant proportion of virgins in this age group.
Various measures of prevalence have been computed for this simulated population: prevalence in the population aged 15-24 is equivalent to a measure for the whole community. Prevalence measures in pregnant women aged 15-24 and aged 15-19 are equivalent to antenatal surveillance measures classified by age. Clearly only sexually active women can become pregnant. Prevalence measures in pregnant women parity 0 (women expecting first birth) and parity 0 & 1 (those expecting first or second birth) are equivalent to antenatal surveillance measures classified by parity. These parity based measures extend across the whole of the simulated age range (10 to 29), and are not confined to the 15-24 age group in which community based incidence and prevalence are measured.
This projection model is used to assess how well trends in HIV prevalence among young antenatal women correlate with HIV incidence trends if changes occur in the age at sexual debut and in the risk of HIV transmission. The various scenarios show the time lag between incidence and prevalence changes, the difference in HIV prevalence trends among all women 15-24 and among pregnant women 15-24, and the sensitivity of age-and parity-based HIV prevalence to changes in age at sexual debut and HIV incidence.
In all three projections shown below, HIV incidence among the sexually active is assumed to rise linearly from year zero, then flattens out at 5% in year 5. In scenario 1 (figure 2a) it falls linearly from year 15, reaching a level of 2% in year 18. (Incidence in the sexually active population and incidence in the 15-24 age group coincide exactly in this simulation, so the trend lines are superimposed throughout.) In scenario 2 (figure 2b) incidence among the sexually active remains constant at 5% for the rest of the projection period, but the pattern of sexual debut is assumed to age rapidly between calendar years 10 and 13, so that after year 13, the age by which 1% have become active has risen from age 12 to age 16, the age at which 99% have become active has risen from 17 to 24. The last scenario (figure 2c) shows the effect of combining a fall in incidence among the sexually active (as in the first scenario) with a rise in age of sexual debut (as in the second scenario).
In scenario 1, trends in the community based prevalence measure for ages 15-24 are echoed closely by trends in prevalence among pregnant women aged 15-24, and by trends for those experiencing first and second births. Trends in prevalence among 15-19 year olds follow a broadly similar pattern, but at a lower overall level. All the pregnant women based prevalence measures as well as the community based measure respond immediately to the decline in incidence rates among the sexually active which starts in year 15. However, there are lags in the responses to the levelling off in incidence, both after the period in which incidence was rising (up to year 5) and after the period of decline in incidence (years 15 to 18).
The reason for these lags is that it takes some time for the relevant age or parity groups to fill up with women who have been subject to the new level of risk for the whole of the time that they typically spend in that group. That is why the lags are longest for the "by parity" grouping of pregnant women: at a constant annual risk of birth of 30% for the sexually active, about half of first births occur within 2 years of the start of sexual activity, but about 10% of second births occur to women who had been sexually active for more than 7 years.
The reason for the more-or-less instant response of all the prevalence measures to the drop in risk at year 15, is that the simulation represents a growing population, so that the youngest single-year cohort with lowest HIV prevalence, which enters observation after the fall in risk is numerically larger than the oldest cohort with the highest prevalence which leaves observation. Again, this relationship is tighter for age-based rather than parity based measures. Figure 2b illustrates the second scenario, in which the decline in incidence that takes place after year 10 is due to a rise in the age at sexual debut. The age range in which 98% of the population is assumed to lose their virginity moves from ages 12-17 to 16-24, eventually producing a fall in incidence in the age group 15-24 from 5% to 2%, even though the risk to the sexually active does not change. Although the change in age pattern of sexual debut takes only 3 years to accomplish (as with the fall in HIV risk in the previous figure) it takes about 7 years for incidence to fall from 5% to 2%, as this is how long it takes the women who had experienced the earlier, faster rates of sexual debut to leave the 15-24 age group and be entirely replaced by women who had experienced only the later, slower sexual debut rates. The community based prevalence measure responds immediately to the beginning of the fall in incidence, but doesn't level out until about year 22, i.e. about 5 years after the community based incidence curve levels out.
The parity based measure stays at its peak values, because it reflects the steady risk experienced by the sexually active -only the sexually active become pregnant, and the distribution of the women experiencing a first birth or second birth by time since start of sexual activity does not change, although their age composition may change as sexual debut patterns change. Since prevalence among the sexually active is determined by length of exposure to sexual activity and by risk level, the prevalence curves by parity for pregnant women stay constant.
The prevalence measure in pregnant women aged 15-24 actually rises for four to five years in response to an increase in the age at sexual debut. This is because among this selected group of pregnant (and therefore sexually active) women the balance of women who have been sexually active for a relatively long time initially increases, as the incoming youngest cohorts are numerically depleted by the lower rates of entry into sexual activity. After some years, those who experienced the earlier pattern of starting sexual activity cease to dominate the age group, and the distribution of pregnant women by duration since sexual debut begins to reflect the new pattern of age at first sex. The HIV prevalence in the age groups of pregnant women then falls very rapidly, even though community incidence in the same age group is levelling off at this stage. The pattern of change in prevalence among 15-19 year old pregnant women is broadly similar to that in 15-24 year olds, but with earlier and steeper rises and falls. Figure 2c illustrates the situation where both sexual debut changes and changes in incidence level among the sexually active occur. Overall, prevalence trends in the parity grouping of pregnant women give a truer representation of incidence trends than prevalence trends in pregnant women categorized by age group. Changes in prevalence among pregnant women classified by parity consistently lag behind population based changes in incidence in the 15-24 age group. Trends in the age based pregnant prevalence measures have an erratic relationship to population based incidence trends, just as in the previous simulation. However, the relationship between the interim peak level of population based incidence and the corresponding final stable incidence level (5% : 1%) is fairly accurately reflected in the approximate relationship between the peak and final values of the age-based measures for pregnant women (12% : 3% in 15-19-year-olds; 20% : 5% in 15-24). In contrast, the peak : final ratio in the parity based measure (20% to 10%) is too low, though it does reflect the ratio for incidence in the sexually active (5% : 2%).
The general conclusion which can be drawn from these illustrations is that lagged parity based measures of prevalence in pregnant women are a consistent indicator of incidence in the subgroup of sexually active women in the community. Although short-term trends in prevalence in young pregnant women classified by age can be misleading as indicators of current incidence trends, once these have been stable for some time, they should be reasonable indicators of stable incidence in the community as a whole. About five years of unchanging prevalence in the 15-24 age group of pregnant women can be taken as evidence of stability, since in this time the 15-19 age group, whose composition is most likely to be affected by changes in age at sexual debut would experience a complete turnover in membership.
Modelling determinants of infection and fertility risk
The projections discussed above were caricatures designed to alert us to the transient differences between prevalence in young pregnant women and women in general which complicate the use of prevalence data from antenatal surveillance as a guide to incidence trends in the general female population. The only explanatory factor explicitly considered was the age pattern of sexual debut. The simulations in which we allowed for a reduction in risk among the sexually active assumed that such changes would have no influence on pregnancy risks. However, some factors which influence HIV transmission risk can also affect fertility. These include some which are the subject of specific intervention strategies, such as increasing condom use and decreasing the prevalence of other STDs. The following simulations illustrate the effects of different levels of such factors on the relationship between incidence, general population prevalence and prevalence in pregnant women. Instead of tracing changes over time, we only compare populations in which incidence and prevalence have stabilised under a variety of conditions. This is equivalent to examining the evolving populations in the first three simulations only in the final "flattening out" phases of the projections.
Since a multi-state projection becomes prohibitively complex if we have to allow for too many time dependent factors simultaneously, the methodology employed here is stochastic microsimulation. In this approach, we model the individual life-courses of women grouped into cohorts of 10,000. Each woman is followed from age 10 to age 50 (or death, whichever occurs earlier), on a monthly basis. She is subject to (mainly empirically determined) risk schedules governing various changes of state affecting fecundity, sexual behaviour and infection. These include experience of menarche, partnership formation, conception, pregnancy outcome, disease transmission and disease progression. Average age and duration specific risks are fixed at the population level, but whether or not a particular woman experiences a change of state in any one month depends on her state as she enters that month (e.g. only a non-pregnant, fecund woman with a sexual partner can become pregnant), and on a randomly determined binomial change-ofstate variable (a pseudo-random number from a uniform zero-one distribution is compared to the appropriate population risk level).
Although this model does not explicitly generate entire male life histories, assumed levels of HIV and other STD infections in the male population determine the risks of encountering an infected partner for females. The model allows us to set different prevalence levels (and corresponding incidence levels) among the population of men from whom casual and cohabiting partners are drawn. It is also possible to specify for (initially HIV negative) male partners in cohabiting unions a changing level of incidence with duration of union, to reflect a changing likelihood of their concurrent involvement with casual partners. Cofactor effects for higher transmission of HIV from an infected partner can be specified for women already infected with other STDs, as can higher risk levels for STD transmission for women who are HIV positive.
Summary statistics on the outcome of all the individual events can be compiled to represent whole cohort experience (as in a prospective or retrospective study); or in a population, by sampling the cohort at an appropriate distribution of ages (to represent cross-sectional measures); or as the women experience pregnancy (to represent an antenatal surveillance sample). The parameters governing the population level risk distributions are shown in appendix B, a more formal mathematical treatment of the simulation procedure and detailed explanation of the model is available in [20] .
Four sets of simulations are discussed below. In the first, we vary the population level parameters governing the duration and re-formation of sexual partnerships and coital frequency within partnerships, distinguishing cohabiting and casual unions. This allows us to vary the exposure to risk of the sexually active, and not just entry into sexual activity and overall risk level as in the first batch of simulations. In the second simulation we examine the effects of prophylactic condom use in casual and cohabiting unions, and in the third we look at infection rates and disease duration for syphilis and the classical sterilising STDs. Finally, we examine the effect of various fetal loss rates among infected and uninfected women on HIV prevalence measures in antenatal clinics. Each simulation set consists of 8 distinct simulations and the default simulation, which appears as the central point in each figure.
Figures 3a to 3d show incidence and prevalence in the general female population 15-24, and prevalence in young pregnant women classified either by age or by parity. The difference between these graphs and figures 2a to 2c is that the x-axis does not represent time, but a measure relating to a specific risk variable. The points on the graph represent the relationships observed in distinct populations between prevalence and incidence measures and the predictor variable. The lines represent regressions of prevalence and incidence measures against the risk determinants.
Figures 3a to 3c show that in the first three simulations prevalence in pregnant women aged 15-24 is broadly similar to prevalence in the general female population of the same age, whereas prevalence in women experiencing first and second births is a little higher. This is because in these micro-simulations we allow for discontinuities in sexual exposure (break-up and reformation of partnerships), so that it takes a little longer for women to reach their second pregnancy, and therefore a larger fraction of these women are in the age group 25 and over. This is a more realistic representation of the situation in real populations than could be achieved with the simple projection model discussed in the previous section.
An impression of the robustness of the prevalence measures as indicators of incidence can be gleaned by comparing the relative scatter of prevalence points about their regression lines compared to the scatter of the incidence points. In these first three simulations the parity based measures perform as well as the age based measures as indicators of incidence. Since point prevalence for these young women is of the order of five times the incidence rate, we would expect the slopes and intercepts of the prevalence regression lines to be consistently proportionately greater than the corresponding incidence relationships. If such consistency is not observed, this warns us that a prevalence measure may be biased if used as an indicator of incidence in comparisons between different steady state populations. Figure 3a confirms that age-and parity-based prevalence measures in pregnant women are reasonable indicators of incidence level when comparing populations experiencing different levels of casual sex. However, community based prevalence in the 15-24 age group is more strongly affected by the extent of casual sexual activity, and would exaggerate incidence rates in this age group if used as a comparative indicator between populations.
All three prevalence measures faithfully reflect incidence levels in populations with different levels of condom use, with virtually no apparent bias, as shown in figure 3b, though the paritybased measure in pregnant women is slightly less robust. This is due to the relatively wide scatter at the lowest rates of condom use, where this measure is more sensitive than the others to the balance of use between casual and cohabiting partnerships.
From figure 3c, we can see that all three prevalence measures would tend to be lower in populations with lower incidence of other STDs. The relationship between HIV prevalence and other STD incidence is stronger than that between HIV incidence and other STD incidence, presumably because we have allowed in our models for HIV positive women to be more prone to subsequently contracting other STDs because they would have less immunity to any infectious disease. Figure 3d shows a very different picture of the prevalence -incidence relationships. In this simulation we have varied the degree of fetal wastage due to vertical transmission of HIV, that is the excess early fetal losses and the still births experienced by the HIV positive. Differences in vertical transmission do not affect incidence (or prevalence) in the general female population.
However, even very small differences in the extent of HIV induced early fetal loss can cause quite large variation in the prevalence measures for pregnant women, particularly in the agebased measure. This is because women who suffered miscarriages in the first trimester would not be seen in antenatal clinics (in this model we assume that the first antenatal consultation takes place in the second trimester). This simulation is not supposed to represent the effect of anti-retroviral treatment for pregnant women, since this would typically be given late in pregnancy and would therefore only affect the still birth rate not early fetal losses. Rather it is an attempt to examine the possible effects of other factors which might enhance vertical transmission in some populations -e.g. vitamin A deficiency or high malaria prevalence. It is worth noting, that in cross regional comparisons, we would encounter similar biases if women were consistently seen at an earlier stage of pregnancy in clinics in one place than in another, as the earlier in pregnancy a woman comes to the antenatal clinic, the more likely she is to be seen, and her HIV status measured before she miscarries. Table 3 presents a summary goodness of fit statistic, showing how well the different prevalence measures illustrated in figures 3a to 3d would perform as indicators of population incidence at ages 15-24 under the assumption of simple proportionality. The goodness of fit is a chi-squared measure, obtained by summing the squares of the proportionate differences between the predicted and actual incidence values in the model, when each of the four determinants discussed above is allowed to vary. Clearly, the community based prevalence measure is a much better predictor of incidence in young women than any of the measures based on prevalence in pregnant women. The measure based on prevalence in 15-19-year-old pregnant women is by far the least satisfactory predictor, with much higher chi-squared values than all the others. The estimates based on prevalence among pregnant women delivering their first or second births perform almost as well as those based on prevalence in pregnant women aged 15-24 for three out of the four determinants considered (coital frequency, condom use, and co-infection with other STDs). However, the parity based measure clearly outperforms the age based measure when the scale of fetal losses due to HIV is allowed to vary between populations, so that the overall chi-squared score over all 32 simulation runs is lower for the parity based predictor.
Discussion
The simulations and projections above have shown that for antenatal clinic based HIV prevalence estimates to be useful as predictors of incidence among young women, the age group used should be wide (15-24 rather than [15] [16] [17] [18] [19] and that it is useful to collect parity based data to complement the age based data. As indicators of incidence, age based estimates and parity based estimates are subject to slightly different biases. Parity-based indicators are better at reflecting the dynamics of infection in the sexually active population, but age-based measures may be better at portraying incidence levels in young women as a whole.
All the prevalence measures lag behind changes in incidence, but age-based prevalence measures in pregnant women may be additionally subject to rapid fluctuations if there are significant changes in the age at sexual debut. This is due to changes in the composition of the age group by time since sexual debut. These prevalence fluctuations in young pregnant women may give the impression that incidence is rising when it is in fact falling, or may give the impression that a very rapid decline is occurring when the pace of the incidence decline due to later sexual debut is quite moderate. However, these effects are transitory, and the stable prevalence level eventually attained in pregnant women aged 15-24 should be a reasonable guide to the stable incidence level in this age group. Comparisons with trends in prevalence among women expecting their first and second births could alert us to spurious transient prevalence trends in the age-based measure, as the parity based measure should be very little affected by changes in age at sexual debut.
With respect to those determinants of changes in infection probability among the sexually active which we have investigated: coital frequency, condom use, and co-infection with other STDs, both the parity-based prevalence measure, and the measure based on prevalence among 15-24-year-old pregnant women perform reasonably well, but prevalence in pregnant 15-19-year-olds is a relatively poor predictor of incidence in 15-24-year-old women. Parity based measures are less affected by inter-population differences in fetal mortality due to vertical transmission of HIVthis is not, of course, a determinant of incidence, but merely another nuisance factor which needs to be taken into account when comparing prevalence levels in pregnant women in different populations.
In a few countries empirical data on HIV prevalence among women attending antenatal clinics have shown that prevalence declines are likely to occur first in the younger antenatal women. For example, in Uganda, such trends were observed from about 1993 [9, 10] ; in Chiang Rai, Thailand, HIV prevalence fell markedly among young childbearing women from 1994 [21] . If such changes occur, careful consideration needs to be given to a number of biases. These include changes in the quality of data collection and HIV testing, utilization of antenatal care (by younger women), and biases related to selection for sexual activity and HIV-associated reduction of fertility [6] . At the national level the selectivity of antenatal HIV sentinel surveillance sites may also present a problem. In most countries rural sites are severely underrepresented.
HIV trend data from other population groups can provide important evidence to support the observed trends in antenatal women. In Uganda, HIV incidence and prevalence trends from population-based cohort studies provided some support for the trends in young antenatal women [22, 23] . In Thailand, a multitude of data source documented a decline in HIV prevalence [24] [25] [26] . The Thai data also indicated a decline in the incidence of other STDs [27] .
From the programme evaluation perspective two important questions follow the observation of a decline in HIV prevalence among younger antenatal women. The first question concerns the extent to which such changes can be attributed to changes in sexual behaviour. If such changes occur, the second question can be posed; to what extent can changes in sexual behaviour be attributed to interventions? In Uganda, survey data on sexual behaviour [9] and modelling [10] were used to assess whether behavioral changes may have caused the decline in HIV prevalence. In Thailand, a very large number of behavioural surveys showed a rapid decline in visits to female sex workers and an increase in condom use [24, 27] . Programme output statistics in both Uganda and Thailand suggested that some of the behavioural changes were associated with interventions.
Our analysis and simulations show that HIV prevalence trends among young antenatal women are a fairly good indicator of HIV incidence trends in most circumstances. A wide age interval should be used (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) rather than five-year age groups and monitoring HIV trends by parity 0 and 1 further enhances the ability of antenatal data to describe true trends. The results strongly suggest that surveillance of the epidemic and monitoring and evaluation of interventions will greatly benefit from a renewed and concerted effort to obtain reliable data on HIV prevalence trends among young women in antenatal clinics at national and sub-national levels [13] .
Appendix A: the projection model
In general, the population aged a+1 at time t+1,
is derived from the population aged a at time t, by considering the action of all decremental forces, ) , ( t a i θ , which might remove women from the cohort. All the forces governing movements between population groups are assumed constant within a single year, so that we can write:
Since we are considering a relatively narrow age range of women, we have assumed the force of mortality from causes other than HIV, o µ , to be the same for all ages and unchanging over time.
The force of mortality due to HIV,
, is assumed to depend only on duration since infection, d.
Subgroups of the population may be subject to decremental forces other than mortality, in particular, the number of virgins,
, is the force of sexual initiation at age a and time t.
The number of HIV negative, sexually active women
is the force of infection among the sexually active at time t, assumed to be independent of age.
The number of newly infected women,
and the number of HIV positive women infected d+1 years ago,
The total number of HIV positive women,
, is obtained by summing across all duration groups:
We have also assumed that the sexually active are subject to a constant fertility force φ , so that the proportion
of sexually active women remaining at the same parity, b, from one year to the next is:
Since φ is independent of age, achieved parity will depend only on duration since sexual debut. Assuming that women cannot experience more than one birth per year, the proportion of women d years after sexual debut at parity b,
We have assumed that the initial population is quasi stable, so that with a growth rate, r, the initial structure can be defined using: 
